Following the latest publication by The Lancet’s of preliminary Phase-3 trial results from the Russian COVID vaccine showing a 91,6 percent efficacy, RT speaks to David Livermore, Professor of Medical Microbiology at the University of East Anglia, about a variety of issues such as western skepticism towards the Russian jab, the question of politicizing the medicine, and co-operation between countries in the fight against COVID.
Check out http://rt.com
Like us on Facebook http://www.facebook.com/RTnews
Follow us on VK https://vk.com/rt_international
Follow us on Twitter http://twitter.com/RT_com
Follow us on Instagram http://instagram.com/rt
Follow us on Soundcloud https://soundcloud.com/rttv
Follow us on Telegram https://t.me/rtintl / https://t.me/rtvisual
#RT (Russia Today) is a global #news network broadcasting from Moscow, London, Paris and Washington studios to over 100 countries. RT is the first news channel to break the 1 billion YouTube views benchmark.